Literature DB >> 30721124

Canadian Urological Association Best Practice Report: Diagnosis and management of radiation-induced hemorrhagic cystitis.

George Goucher1, Fred Saad2, Himu Lukka3, Anil Kapoor1.   

Abstract

Entities:  

Year:  2019        PMID： 30721124      PMCID： PMC6363576          DOI： 10.5489/cuaj.5788

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  63 in total

Review 1.  The management of intractable haematuria.

Authors:  S K Choong; M Walkden; R Kirby
Journal:  BJU Int       Date:  2000-12       Impact factor: 5.588

2.  Use of fibrin sealant in recalcitrant hemorrhagic cystitis.

Authors:  Michael K Ouwenga; Matthew D Langston; Steven C Campbell
Journal:  J Urol       Date:  2004-10       Impact factor: 7.450

Review 3.  The use of hyperbaric oxygen in urology.

Authors:  M Capelli-Schellpfeffer; G S Gerber
Journal:  J Urol       Date:  1999-09       Impact factor: 7.450

4.  Late radiation effects to the rectum and bladder in gynecologic cancer patients: the comparison of LENT/SOMA and RTOG/EORTC late-effects scoring systems.

Authors:  Y Anacak; D Yalman; Z Ozsaran; A Haydaroğlu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-08-01       Impact factor: 7.038

5.  Intravesicle formalin instillation with a modified technique for controlling haemorrhage secondary to radiation cystitis.

Authors:  B Lojanapiwat; S Sripralakrit; S Soonthornphan; S Wudhikarn
Journal:  Asian J Surg       Date:  2002-07       Impact factor: 2.767

6.  A phase II study to evaluate WF10 in patients with late hemorrhagic radiation cystitis and proctitis.

Authors:  Vutisiri Veerasarn; Wiroon Boonnuch; Chumpot Kakanaporn
Journal:  Gynecol Oncol       Date:  2005-09-19       Impact factor: 5.482

Review 7.  Encephalopathy after bladder irrigation with alum: case report and literature review.

Authors:  K R Phelps; K Naylor; T P Brien; H Wilbur; S S Haqqie
Journal:  Am J Med Sci       Date:  1999-09       Impact factor: 2.378

8.  Intravesical epsilon aminocaproic acid in management of intractable bladder hemorrhage.

Authors:  I Singh; G B Laungani
Journal:  Urology       Date:  1992-09       Impact factor: 2.649

9.  The management of haemorrhagic cystitis with sodium pentosan polysulphate.

Authors:  Sarbjinder S Sandhu; Miles Goldstraw; Christopher R J Woodhouse
Journal:  BJU Int       Date:  2004-10       Impact factor: 5.588

10.  Reduced recurrence of late hemorrhagic radiation cystitis by WF10 therapy in cervical cancer patients: a multicenter, randomized, two-arm, open-label trial.

Authors:  Vutisiri Veerasarn; Chonlakiet Khorprasert; Vicharn Lorvidhaya; Supatra Sangruchi; Thanatip Tantivatana; Ladawan Narkwong; Yongyut Kongthanarat; Imjai Chitapanarux; Chanawat Tesavibul; Apichart Panichevaluk; Sirisak Puribhat; Somphob Sangkittipaiboon; Lak Sookpreedee; Prasert Lertsanguansinchai; Pramook Phromratanapongse; Poonkiat Rungpoka; Supamitr Trithratipvikul; Bannakij Lojanapiwat; Sathit Ruangdilokrat; Pichai Ngampanprasert
Journal:  Radiother Oncol       Date:  2004-11       Impact factor: 6.280
View more
  3 in total

Review 1.  [Radiation-induced hemorrhagic cystitis-possible treatment options!]

Authors:  P Nuhn; J Thüroff
Journal:  Urologie       Date:  2022-05-30

2.  Radiation-induced haemorrhagic cystitis after prostate cancer radiotherapy: factors associated to hospitalization and treatment strategies.

Authors:  Francesco Sanguedolce; Gemma Sancho Pardo; Asier Mercadé Sanchez; Josep Balaña Lucena; Francesca Pisano; Julio Calderón Cortez; Angelo Territo; Jordi Huguet Perez; Josep Gaya Sopeña; Cristina Esquina Lopez; Alberto Breda; Joan Palou Redorta
Journal:  Prostate Int       Date:  2020-08-11

Review 3.  Impact of radiotherapy for localized prostate cancer on bladder function as demonstrated on urodynamics study: A systematic review.

Authors:  Henry Han-I Yao; Venetia Hoe; Samer Shamout; Shomik Sengupta; Helen E O'Connell; Kevin V Carlson; Richard J Baverstock
Journal:  Can Urol Assoc J       Date:  2021-12       Impact factor: 1.862
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.